MASSACHUSETTS GENERAL HOSPITAL
Department of Pharmacy
Department of Nursing
Critical Care
Generic Name: |
Anti-Thymocyte Globulin (Rabbit), Rabbit ATG |
Trade Name: |
Thymoglobulin |
Action: |
Immunosuppression by destruction of thymus derived lymphocytes byphagocytosis |
Indications: |
Prevention or treatment of organ transplant rejection |
Usual Dose: |
MD ORDER SHOULD SPECIFY SOURCE (e.g. Rabbit) Prophylaxis: 1 – 2 mg/kg/day for 5 to 14 days Treatment: 1.5 mg/kg/day for 7 to 14 days ADMINISTER FIRST DOSE OVER 6 HOURS. Subsequent doses may be infused over 4 hours through a high-flow vein. |
Standard Concentration: |
Dilute in either 0.45% Sodium Chloride or 0.9% Sodium Chloride ONLY Maximum concentration is 0.5 mg/mL |
Administration Guidelines: |
Administer via 0.22-micr on in-line filter. A dedicated line required for administration; do not give with other parenteral medications or carrier. Central line preferred for venous administration. In cases of emergency or extenuating circumstances, Rabbit ATG may be given peripherally into a high-flow vein while preparation for central line is underway using at least a 2-inch peripheral IV cannula. Prepared solutions must be used immediately. Under refrigeration, solution is stable for 24 hours. |
Special Considerations: |
To prevent foaming, aspirate medication carefully Do not shake IV once mixed to prevent denaturation of the proteins Premedication to reduce adverse reactions:
CBC should be drawn prior to administration (baseline CBC to monitor for leukopenia & thrombocytopenia) Concomitant immunosuppression may be reduced during treatment |
Precautions and Side Effects: |
Chills, fever may occur with first dose Leukopenia (57%) and Thrombocytopenia (36%) Local inflammatory reaction if venous extravasation occurs Hypertension, tachycardia, peripheral edema, myalgia Headache, nausea, vomiting, diarrhea |
12/06-MESAC Approved